Current and historical daily PE Ratio for 4SC AG (
XTER:VSC
) from 2005 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. 4SC AG stock (XTER:VSC) PE ratio as of Apr 23 2024 is 0.
More Details
4SC AG (XTER:VSC) PE Ratio (TTM) Chart
4SC AG (XTER:VSC) PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Total 931
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| 4SC AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-23 | At Loss | 2022-12-07 | At Loss |
| 2023-02-09 | At Loss | 2022-12-06 | At Loss |
| 2023-02-08 | At Loss | 2022-12-05 | At Loss |
| 2023-02-07 | At Loss | 2022-12-02 | At Loss |
| 2023-02-06 | At Loss | 2022-12-01 | At Loss |
| 2023-02-03 | At Loss | 2022-11-30 | At Loss |
| 2023-02-02 | At Loss | 2022-11-29 | At Loss |
| 2023-02-01 | At Loss | 2022-11-28 | At Loss |
| 2023-01-30 | At Loss | 2022-11-25 | At Loss |
| 2023-01-27 | At Loss | 2022-11-24 | At Loss |
| 2023-01-26 | At Loss | 2022-11-23 | At Loss |
| 2023-01-25 | At Loss | 2022-11-22 | At Loss |
| 2023-01-24 | At Loss | 2022-11-21 | At Loss |
| 2023-01-23 | At Loss | 2022-11-18 | At Loss |
| 2023-01-20 | At Loss | 2022-11-17 | At Loss |
| 2023-01-19 | At Loss | 2022-11-16 | At Loss |
| 2023-01-18 | At Loss | 2022-11-15 | At Loss |
| 2023-01-17 | At Loss | 2022-11-14 | At Loss |
| 2023-01-16 | At Loss | 2022-11-11 | At Loss |
| 2023-01-13 | At Loss | 2022-11-10 | At Loss |
| 2023-01-12 | At Loss | 2022-11-09 | At Loss |
| 2023-01-11 | At Loss | 2022-11-08 | At Loss |
| 2023-01-10 | At Loss | 2022-11-07 | At Loss |
| 2023-01-09 | At Loss | 2022-11-04 | At Loss |
| 2023-01-06 | At Loss | 2022-11-03 | At Loss |
| 2023-01-05 | At Loss | 2022-11-02 | At Loss |
| 2023-01-04 | At Loss | 2022-11-01 | At Loss |
| 2023-01-03 | At Loss | 2022-10-28 | At Loss |
| 2023-01-02 | At Loss | 2022-10-27 | At Loss |
| 2022-12-30 | At Loss | 2022-10-26 | At Loss |
| 2022-12-29 | At Loss | 2022-10-25 | At Loss |
| 2022-12-28 | At Loss | 2022-10-24 | At Loss |
| 2022-12-27 | At Loss | 2022-10-21 | At Loss |
| 2022-12-23 | At Loss | 2022-10-20 | At Loss |
| 2022-12-22 | At Loss | 2022-10-19 | At Loss |
| 2022-12-21 | At Loss | 2022-10-18 | At Loss |
| 2022-12-20 | At Loss | 2022-10-17 | At Loss |
| 2022-12-19 | At Loss | 2022-10-14 | At Loss |
| 2022-12-16 | At Loss | 2022-10-13 | At Loss |
| 2022-12-15 | At Loss | 2022-10-12 | At Loss |
| 2022-12-14 | At Loss | 2022-10-11 | At Loss |
| 2022-12-13 | At Loss | 2022-10-10 | At Loss |
| 2022-12-12 | At Loss | 2022-10-07 | At Loss |
| 2022-12-09 | At Loss | 2022-10-06 | At Loss |
| 2022-12-08 | At Loss | 2022-10-05 | At Loss |
4SC AG (XTER:VSC) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
4SC AG
ISIN : DE000A3E5C40
Compare
Compare
Traded in other countries / regions
VSC.Germany0R6U.UK IPO Date
2005-12-15Description
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers